Presentations -
-
Komarovieuinone-derivatives, revealed anti-tumor effect on high-risk multiple myeloma cells in vitro as well as in vivo
Mariko Sato, Shotaro Kitabatake, Daiju Ichikawa, Yutaka Suto, Genji Iwasaki, FUmiyuki Kiuchi, Takashi Yamaguchi, Arimi Ueda,Shuji Aida,Matsushita Maiko,Yutaka Hattori
58th American Society of Hematology Annual Meeting and Exposition (San Diego) ,
2016.12,Poster presentation
-
Immunomodulatory Effects of Proteasome Inhibitors in Multiple Myeloma.
Sho Kashiwazaki, Satoshi Kamiko, Ryo Uozaki, Tomofumi Yamamoto, Daiju Ichikawa, Yutaka Hattori, Matsushita Maiko Matsushita, Maki Hirao, Hisako Kunieda and Kohei Yamazaki
60th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (San Diego CA.) ,
2016.12,Poster presentation
-
Structual optimization and anti-tumo activities of komaroviquinone to high-risk myeloma
Mariko Sato, Shotaro Kitabatake, Daiju Ichikawa, Yutaka Suto, Genji Iwasaki, FUmiyuki Kiuchi, Takashi Yamaguchi, Arimi Ueda,Shuji Aida,Matsushita Maiko,Yutaka Hattori
第78回日本血液学会学術集会 (横浜市) ,
2016.10,Oral presentation (general)
-
本邦における造血器腫瘍薬市場の現状と今後の展望
柴田翔洋,和山祐亮,露木愛,松下 麻衣子,松木絵里,岡本真一郎,鈴木岳之
第14回日本臨床腫瘍学会学術集会 (神戸市) ,
2016.07,Poster presentation
-
Immunogenicity of Novel Antigen Expressed in Leukemia Stem Cells.
Ozawa K, Matsushita M, Yokoe S, Kanchi S, Uchiumi A , Ichikawa D , Matsuki E , Sakurai M, Karigane D, Kasahara H , Kawakami Y , Okamoto S, Hattori Y.
The 5thJCA-AACR Joint Conference,
2016.07,Poster presentation
-
ハイリスク多発性骨髄腫に対する新規komaroviquinone誘導体による克服薬の開発
佐藤真梨子,北畠翔太朗,藤森宏太,市川大樹,須藤豊,岩崎源司,木内文之,山口高史,植田有美,會田宗司,松下 麻衣子,服部豊
第41回日本骨髄腫学会学術集会 (徳島市) ,
2016.05,Poster presentation
-
Identification of Novel HLA-A*24:02-Restricted Epitope Derived from PEPP2 Expressed in Hematological Malignancies.
Uchiumi A, Matsushita M, Otsuka Y, Tsutsumida N, Tanaka C, Ozawa K, Suzuki T, Ichikawa D,Okamoto S, Kawakami Y, Hattori Y.
The 7th JSH International Symposium,
2016.05,Poster presentation
-
Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs.
Hozumi M, Ichikawa D, Matsushita Maiko, Kamiyama E, Yanagawa H, Tabata N, Kitabatake S, Ueda A, Yamaguchi T, Sato M, Hattori Y.
57th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. (Orlando, FL. U.S.A.) ,
2015.12,Poster presentation
-
Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI.
Matsushita MaikoKoji Ozawa, Kanchi S, Uchiumi A, Suzuki T, Ichikawa D, Matsuski E, Sakurai M, Karigane D, Nakajima H, Okamoto S, Hattori Y.
30th Annual Meeting of The Society for Immunotherapy of Cancer（SITC） (National Harbor, MD, U.S.A.) ,
2015.11,Poster presentation, The Society for Immunotherapy of Cancer（SITC）
-
Identification of New IMiDs-Binding Proteins and Nonteratogenic Drug Design for High-Risk Myeloma.
Hozumi M,Matsushita Maiko, Ichikawa D, Ozaki Y, Hasegawa Y, Terada F, Yanagawa H, Tabata N, Shiheido H, Oikawa T, Matsuo K, Yamada T, Wenlin Du W, Kitabatake S, Ueda A, Hattori Y
第77回日本血液学会 (石川県立音楽堂) ,
2015.10,Oral presentation (general), 日本血液学会
-
イマチニブ投与中止後CML患者におけるがん幹細胞抗原特異的CTLの解析.
神地沙織,小澤光司,松下 麻衣子,松木絵里,櫻井政寿,雁金大樹,市川大樹,岡本真一郎,服部豊.
第７回血液疾患免疫療法研究会学術集会 (東京大学 伊藤謝恩ホール) ,
2015.09,Oral presentation (general), 血液疾患免疫療法研究会
-
ハイリスク多発性骨髄腫に対する新規治療薬の開発
Matsushita Maiko
第16回 Pharmaco-Hematologyシンポジウム（日本薬学会生物系薬学部会）,
2015.06,Oral presentation (general)
-
白血病幹細胞に発現する新規がん精巣抗原の同定
Matsushita Maiko
第12回日本免疫治療学研究会学術集会,
2015.02,Poster presentation
-
Clinical and biological significance of codon 72 polymorphisms of TP53 gene in multiple myeloma.
Masashi Hozumi, Yurika Ikeda, Yuya Suzuki, Maiko Matsushita, Daiju Ichikawa, Arimi Ueda, Shotaro Kitabatake, Yutaka Hattori
The 76th Annual Meeting of the Japanese Society of Hematology,
2014.10,Oral presentation (keynote)
-
Identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
〇Matsushita M, Nakamura M, Ichikawa D, Tsukamoto N, Kawakami Y, Hattori Y.
43rd Annual Scientific Meeting of Society for Hematology and Stem Cells (Montreal, Canada) ,
2014.08 -
identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
○Nakamura M, Matsushita M, Ichkawa D, Tsukamoto N, Kawakami Y, Hattori Y.
日本免疫学会総会2013学術集会 (幕張) ,
2013.12 -
Codon 72 Polymorphism Of TP53 Gene Is a Novel Prognostic Marker For Thalidomide Therapy In Multiple Myeloma.
○Hattori Y, Ikeda Y, Suzuki Y, Ichikawa D, Matsushita M.
2013 Annual meeting of American Society of Hematology (New Orleans) ,
2013.12 -
A myeloma cell line established from a patient refractory to thalidomide therapy.
○Ueda A, Matsunami S, Du W, Yamada T, Mori S, Ichikawa D, Matsushita M, Hattori Y.
第75回日本血液学会学術集会 (札幌) ,
2013.10 -
骨髄性白血病に対する免疫療法を目的としたHLA-A*2402拘束性PEPP2由来エピトープペプチドの同定.
○田中千晶, 大塚洋平, 松下麻衣子, 市川大樹, 油谷浩幸, 河上裕, 服部豊.
第72回日本癌学会学術総会 (横浜) ,
2013.10 -
Impact of novel agents to the additional-chromosomal abnormalities in patients with multiple myeloma.
○Hamano A, Abe Y, Miyazaki K, Sekine R, Tsukada N, Nakagawa Y, Kanno K, Hashimoto S, Ichikawa D, Matsushita M, Hattori Y, Suzuki K.
第75回日本血液学会学術集会 (札幌) ,
2013.10